MRAM
Everspin Technologies, Inc.
MRAM's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over MRAM overall, supported by stronger valuation and stronger fundamentals.
MRAM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
MRAM's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
MRAM PE Valuation
MRAM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 105x next year's earnings.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
MRAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect MRAM to return to profit, with revenue growing. However, they disagree widely on these estimates.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
MRAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.12 | — |
| Q3 2026 | -$0.40 | -$0.39 |
MRAM lost $0.40 per share over the past year, a bigger loss than the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over MRAM in the latest year-over-year earnings comparison.
MRAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.6M | +47% |
| Q2 2026 | $18.7M | +42% |
| Q1 2026 | $14.9M | +13% |
| Q4 2025 | $14.8M | +12% |
MRAM's revenue has grown year over year every quarter since late 2025: $21M last quarter, up 47% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -23% | -8.5 points |
| Q1 2026 | -18% | -3.6 points |
| Q4 2025 | -7.2% | +4.5 points |
| Q3 2025 | -11% | N/A |
| Q2 2025 | -15% | N/A |
| Q1 2025 | -15% | N/A |
| Q4 2024 | -12% | N/A |
MRAM's operating margin was −23% last quarter, down 8.5 points from the same quarter a year ago, near the bottom of its range since 2024.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over MRAM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over MRAM on profitability, with a higher operating margin.
MRAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.2M | -138% |
| Q1 2026 | -$3.8M | -818% |
| Q4 2025 | -$975K | -147% |
MU has the edge over MRAM in the latest year-over-year cash flow comparison.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over MRAM in the latest year-over-year cash flow comparison.
MRAM Net Leverage
MRAM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
MRAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 19.9 | Oversold |
MRAM's weekly RSI is 44 (neutral) and its Stochastic is 20 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
MRAM PE vs Technology Sector
| Metric | MRAM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MRAM has no meaningful PE right now: it lost money over the past year.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
MRAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.7 | 12% below |
| 20 week MA | $15.8 | 18% below |
| 50 week MA | $15.7 | 17% below |
| 100 week MA | $11.2 | 16% above |
| 200 week MA | $9.38 | 38% above |
MRAM has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 38% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over MRAM on trend strength, trading above more of its moving averages.
MRAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.38 | $4.64 | -14% |
| 2021 | $4.64 | $11.1 | +139% |
| 2022 | $11.1 | $5.27 | -53% |
| 2023 | $5.27 | $9.04 | +72% |
| 2024 | $9.04 | $6.57 | -27% |
| 2025 | $6.57 | $9.38 | +43% |
| 2026 YTD | $9.38 | $12.9 | +38% |
MRAM's yearly returns have swung widely, from +139% in 2021 to −53% in 2022. It's up 38% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over MRAM on returns for 2026, with the stronger performance.